These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 36539655)
1. SARS-CoV-2-mediated liver injury: pathophysiology and mechanisms of disease. Choaib A; Issa E; El Choueiry F; Eldin JN; Shbaklo K; Alhajj M; Sawaya RT; Assi G; Nader M; Chatila R; Faour WH Inflamm Res; 2023 Feb; 72(2):301-312. PubMed ID: 36539655 [TBL] [Abstract][Full Text] [Related]
2. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027 [TBL] [Abstract][Full Text] [Related]
3. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE Front Immunol; 2021; 12():749291. PubMed ID: 34867978 [TBL] [Abstract][Full Text] [Related]
4. Flavonoids against the SARS-CoV-2 induced inflammatory storm. Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680 [TBL] [Abstract][Full Text] [Related]
5. Covid-19 and development of heart failure: mystery and truth. Onohuean H; Al-Kuraishy HM; Al-Gareeb AI; Qusti S; Alshammari EM; Batiha GE Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2013-2021. PubMed ID: 34480616 [TBL] [Abstract][Full Text] [Related]
6. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Amere Subbarao S Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711 [TBL] [Abstract][Full Text] [Related]
7. Fighting the storm: could novel anti-TNFα and anti-IL-6 Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050 [TBL] [Abstract][Full Text] [Related]
8. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158 [TBL] [Abstract][Full Text] [Related]
9. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel. Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622 [TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748 [TBL] [Abstract][Full Text] [Related]
12. Inflammation inhibitory activity of green tea, soybean, and guava extracts during Sars-Cov-2 infection through TNF protein in cytokine storm. Priyandoko D; Widowati W; Kusuma HSW; Afifah E; Wijayanti CR; Rizal R; Sholihah IA; Permatasari GW; Ramadhani A; Utomo DH Comput Biol Chem; 2023 Aug; 105():107898. PubMed ID: 37247574 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm. Batista Simões JL; Sobierai LD; Pereira SM; Rodrigues Dos Santos MV; Bagatini MD Curr Pharm Des; 2022; 28(22):1798-1814. PubMed ID: 35838210 [TBL] [Abstract][Full Text] [Related]
14. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology. Suárez-Reyes A; Villegas-Valverde CA MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614 [TBL] [Abstract][Full Text] [Related]
15. Colchicine in the management of Covid-19: With or lieu of evidence. Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Al-Gareeb AI J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S127-S132. PubMed ID: 35130235 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828 [TBL] [Abstract][Full Text] [Related]
18. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options. Nazerian Y; Ghasemi M; Yassaghi Y; Nazerian A; Hashemi SM Int Immunopharmacol; 2022 Dec; 113(Pt B):109428. PubMed ID: 36379152 [TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1: A feasible link between liver pathologies and COVID-19. Benedicto A; García-Kamiruaga I; Arteta B World J Gastroenterol; 2021 Jun; 27(24):3516-3529. PubMed ID: 34239266 [TBL] [Abstract][Full Text] [Related]
20. Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection. Marmitt DJ Inflammopharmacology; 2022 Jun; 30(3):749-773. PubMed ID: 35389124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]